In turn, it was demonstrated, that metformin inhibited HIF1A and suppressed the expression of glucose transporters (GLUT1, GLUT3) and regulatory enzymes of the glycolytic pathway in cervical tumor cells [28]. The gene discussed is SLC2A1; the disease is uterine cervix neoplasm.